PTAB challenges

Proceedings overview

There is one active AIA trial proceeding on file for US Patent 10,539,851. This Inter Partes Review (IPR) is currently pending, meaning no claims have been invalidated or sustained by the PTAB yet. The defensive posture for a defendant facing assertion of this patent is that the patent is currently undergoing challenge, with an IPR petition recently filed.

IPR2026-00367 — Ambilight Inc v. Lannray Optoelectronics Zhenjiang Co Ltd

• Type: Inter Partes Review
• Filed: 2026-05-18
• Status: Pending. This IPR was very recently filed and is in its initial stages, awaiting a decision on institution.
• Judge panel: Information regarding the assigned judge panel is not yet publicly available for this recently filed IPR.
• Petition grounds: Details of the claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) for the petition are not yet publicly available or have not been processed into searchable databases due to the very recent filing date.
• Institution decision: Not yet issued. The PTAB typically has several months to decide whether to institute an IPR after the preliminary response.
• Final Written Decision: Not applicable; an institution decision has not yet been issued.
• Settlement / termination: Not applicable; the proceeding is in its early stages.
• Appeal: Not applicable; an appeal to the Federal Circuit can only occur after a Final Written Decision.
• Defensive value: As this IPR is merely pending, it signifies that the patent's validity is currently under challenge. For a defendant, this means potential invalidation grounds are being explored, but no claims have been affected yet. The outcome of this IPR could significantly impact future assertion strategies.

Strategic summary

Currently, all claims of US Patent 10,539,851 (claims 1-20) are UNTESTED by a Final Written Decision from the PTAB. There are no claims that have been CANCELED or SUSTAINED through an AIA trial proceeding to date. The sole IPR (IPR2026-00367) is in its very nascent stages, with the petition having been filed only yesterday.

Regarding the estoppel landscape, since no institution decision has been rendered, there is no estoppel under § 315(e)(2) for the petitioner Ambilight Inc or its privies at this time. Should the IPR be instituted and proceed to a Final Written Decision, estoppel would apply to any claims addressed by the decision, preventing the petitioner from raising grounds that were raised or reasonably could have been raised in a subsequent civil action or ITC proceeding. For any other potential defendant not privy to Ambilight Inc, the full scope of prior-art grounds remains available.

There are no apparent pattern signals such as multiple IPR filings by the same petitioner or aggressive PTAB appeals by the patent owner, as this is the first and only reported AIA trial proceeding for this patent. Similarly, there is no indication of a defensive aggregator like Unified Patents in the chain for this specific patent.

Recommended next steps

Given that IPR2026-00367 is in its earliest stage:

• Monitor the PTAB docket for IPR2026-00367 closely to ascertain the specific grounds of unpatentability asserted by Ambilight Inc and to track key procedural events. The patent owner, Lannray Optoelectronics Zhenjiang Co Ltd, will likely file a preliminary response.
• The institution decision is a critical milestone, as it will determine which claims (if any) proceed to trial. The deadline for the institution decision is typically six months after the preliminary response, or six months after the petition filing if no preliminary response is filed.
• Review the petition once it becomes publicly available to understand the strength of the invalidity arguments presented. This will inform whether a defensive strategy could align with or benefit from the IPR's progress.

There is no PTAB activity beyond this recently filed IPR, meaning the patent has not been subjected to prior administrative review. The absence of previous IPRs on a patent that has been issued since January 2020 could be a signal that it has not been widely asserted or deemed a high-value target for invalidation by others until now.

Proceedings overview

There is one active AIA trial proceeding on file for US Patent 10,539,851. This Inter Partes Review (IPR) is currently pending, meaning no claims have been invalidated or sustained by the PTAB yet. The defensive posture for a defendant facing assertion of this patent is that the patent is currently undergoing challenge, with an IPR petition recently filed.

IPR2026-00367 — Ambilight Inc v. Lannray Optoelectronics Zhenjiang Co Ltd

• Type: Inter Partes Review
• Filed: 2026-05-18
• Status: Pending. This IPR was very recently filed and is in its initial stages, awaiting a decision on institution.
• Judge panel: Information regarding the assigned judge panel is not yet publicly available for this recently filed IPR.
• Petition grounds: Details of the claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) for the petition are not yet publicly available or have not been processed into searchable databases due to the very recent filing date.
• Institution decision: Not yet issued. The PTAB typically has several months to decide whether to institute an IPR after the preliminary response. Since October 20, 2025, the USPTO Director decides whether to institute IPR and post-grant review (PGR) trials.
• Final Written Decision: Not applicable; an institution decision has not yet been issued.
• Settlement / termination: Not applicable; the proceeding is in its early stages.
• Appeal: Not applicable; an appeal to the Federal Circuit can only occur after a Final Written Decision.
• Defensive value: As this IPR is merely pending, it signifies that the patent's validity is currently under challenge. For a defendant, this means potential invalidation grounds are being explored, but no claims have been affected yet. The outcome of this IPR could significantly impact future assertion strategies.

Strategic summary

Currently, all claims of US Patent 10,539,851 (claims 1-20) are UNTESTED by a Final Written Decision from the PTAB. There are no claims that have been CANCELED or SUSTAINED through an AIA trial proceeding to date. The sole IPR (IPR2026-00367) is in its very nascent stages, with the petition having been filed only on May 18, 2026.

Regarding the estoppel landscape, since no institution decision has been rendered, there is no estoppel under § 315(e)(2) for the petitioner Ambilight Inc or its privies at this time. Should the IPR be instituted and proceed to a Final Written Decision, estoppel would apply to any claims addressed by the decision, preventing the petitioner from raising grounds that were raised or reasonably could have been raised in a subsequent civil action or ITC proceeding. For any other potential defendant not privy to Ambilight Inc, the full scope of prior-art grounds remains available.

There are no apparent pattern signals such as multiple IPR filings by the same petitioner or aggressive PTAB appeals by the patent owner, as this is the first and only reported AIA trial proceeding for this patent. Similarly, there is no indication of a defensive aggregator like Unified Patents in the chain for this specific patent.

Recommended next steps

Given that IPR2026-00367 is in its earliest stage:

• Monitor the PTAB docket for IPR2026-00367 closely to ascertain the specific grounds of unpatentability asserted by Ambilight Inc and to track key procedural events. The patent owner, Lannray Optoelectronics Zhenjiang Co Ltd, will likely file a preliminary response.
• The institution decision is a critical milestone, as it will determine which claims (if any) proceed to trial. The deadline for the institution decision is typically six months after the preliminary response, or six months after the petition filing if no preliminary response is filed.
• Review the petition once it becomes publicly available (e.g., on the USPTO PTAB Open Data Portal) to understand the strength of the invalidity arguments presented. This will inform whether a defensive strategy could align with or benefit from the IPR's progress.

There is no PTAB activity beyond this recently filed IPR, meaning the patent has not been subjected to prior administrative review. The absence of previous IPRs on a patent that has been issued since January 2020 could be a signal that it has not been widely asserted or deemed a high-value target for invalidation by others until now.